Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03513029
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- VytronUS, Inc.
- Registry
-
NCT03513029
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Unknown status
Technical summary
Registry record NCT03513029. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-20 (actual); primary completion 2019-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
- Acronym
- VITAL
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- VytronUS Ablation System
- Lead sponsor
- VytronUS, Inc.
Record details
- Record id
cardio:ct-nct03513029- Content hash
d7a91fdb6df8f569be0e9f4632e31f8b416b7792165542cb52ec1a9d79c32731